Motilal Oswal has initiated coverage on Aster DM Quality Care with a Buy rating and Rs 910 target, citing merger synergies, capacity expansion and improving operating metrics. The brokerage expects revenue, EBITDA and PAT to grow at CAGRs of 19.5%, 25% and 33%, respectively, through FY28.
Motilal Oswal has initiated coverage on Aster DM Quality Care with a Buy rating and Rs 910 target, citing merger synergies, capacity expansion and improving operating metrics. The brokerage expects revenue, EBITDA and PAT to grow at CAGRs of 19.5%, 25% and 33%, respectively, through FY28.
<iframe src="https://hindustansphere.com/embed/cluster/855d8263602a04b172a1642c0aebe127496188d2" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Motilal Oswal sees Aster DM EBITDA rising 25% CAGR through FY28; sets Rs 910 target"></iframe>
